Creating 3D-printed bioinks for regenerating bone tissue

In situ bioprinting of high-density cell-laden core-shell microgel bioinks enabling cellular condensation for vascularized bone tissue regeneration

['FUNDING_OTHER'] · JESSE BROWN VA MEDICAL CENTER · NIH-11072099

This study is exploring a new way to help military personnel and veterans heal from bone injuries in their face by using 3D printing to create special gels filled with stem cells that can be placed directly into the body to help grow new bone tissue.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorJESSE BROWN VA MEDICAL CENTER (nih funded)
Locations1 site (CHICAGO, UNITED STATES)
Trial IDNIH-11072099 on ClinicalTrials.gov

What this research studies

This research focuses on developing a new method for regenerating craniofacial bone tissue in military personnel and veterans who have suffered injuries from combat. The approach involves using advanced 3D bioprinting technology to create biodegradable microgels that are loaded with human mesenchymal stem cells. These microgels can be implanted directly into the body without needing prior lab culture, allowing for immediate tissue formation and integration. By customizing the structure of these bioinks, the research aims to match the specific bone defects of individual patients, enhancing the potential for successful regeneration.

Who could benefit from this research

Good fit: Ideal candidates for this research are military personnel and veterans who have experienced significant craniofacial bone damage due to combat-related injuries.

Not a fit: Patients with non-combat related bone injuries or those who do not have craniofacial bone damage may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could provide a groundbreaking solution for effectively regenerating functional bone tissue in patients with severe injuries.

How similar studies have performed: While the approach of using 3D bioprinting for tissue regeneration is innovative, similar strategies have shown promise in other areas of regenerative medicine, indicating potential for success.

Where this research is happening

CHICAGO, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.